Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
March 26, 2019 Off

Transgene and BioInvent Extend their Collaboration to Develop Multifunctional Oncolytic Viruses for the Treatment of Solid Tumors

By BusinessWire

STRASBOURG, France & LUND, Sweden–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/InvirIO?src=hash" target="_blank"gt;#InvirIOlt;/agt;–Regulatory News: Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops…

March 25, 2019 Off

OtiTopic Moves towards Its Clinical Phase with Dry Powder Inhalation of Aspirin to Reduce the Risk of Vascular Mortality in Patients with Suspected Acute Myocardial Infarction (Ml)

By BusinessWire

New England Journal of Medicine Study Reports Harmful Side Effects of Daily Aspirin LOS ANGELES–(BUSINESS WIRE)–Extensive studies on the effects…

March 25, 2019 Off

Bio-Rad Laboratories, Inc. Receives Expected NYSE Notice Regarding Late Form 10-K Filing

By BusinessWire

HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products,…

March 25, 2019 Off

Celgene Submits Application to FDA for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis

By BusinessWire

SUMMIT, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/MS?src=hash" target="_blank"gt;#MSlt;/agt;–Celgene Corporation (NASDAQ:CELG) today announced that the Company has submitted a New Drug Application to the…

March 25, 2019 Off

Arcus Biosciences Appoints Rekha Hemrajani as Chief Operating and Financial Officer

By BusinessWire

HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, today announced the appointment…

March 25, 2019 Off

Oragenics Announces Closing of $12.5 Million Underwritten Public Offering

By BusinessWire

TAMPA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective…

March 25, 2019 Off

Physicians’ Education Resource® Presents “Cutting CVD Risk by Adding PCSK9 Inhibitors: What the Internist Needs to Know”

By BusinessWire

This live symposium will be held adjunct to the 2019 American College of Physicians Internal Medicine Meeting CRANBURY, N.J.–(BUSINESS WIRE)–lt;a…

March 25, 2019 Off

2018 Biotechnology Research Review – Significant Developments, like CRISPR & Spheroids for Drug Development, Have Aided & Accelerated Market Development & Growth – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “2018 Biotechnology Research Review” report has been added to ResearchAndMarkets.com’s offering. Several significant developments have aided and accelerated…

March 25, 2019 Off

Gelesis Presents Expanded Data Showing Impact of Gelesis100 Hydrogel on Patients with Prediabetes, Untreated Diabetes, and Elevated Insulin Resistance

By BusinessWire

Individuals with prediabetes and those with untreated type 2 diabetes had six times higher odds to achieve ≥10% weight loss…

March 25, 2019 Off

Gelesis Presents Preclinical Data Showing Proprietary Hydrogel Restores Gut Barrier Function

By BusinessWire

Treatment with Gelesis hydrogel prevented unwanted substances from entering the circulation in mice with severe gut wall injury Data suggest…

Posts pagination

Previous 1 … 3,333 3,334 3,335 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine